Timothy J. Scannell Appointed to Collagen Matrix Board of Directors

Mr. Scannell most recently served as President and Chief Operating Officer of Stryker.

Collagen Matrix Inc., a leader in regenerative medicine, global manufacturer of collagen and mineral-based medical devices, and Linden Capital Partners portfolio company, announced today the appointment of Timothy J. Scannell to its board of directors. A seasoned and dynamic medical device leader, Mr. Scannell most recently served as President and Chief Operating Officer of Stryker.

Timothy J. Scannell brings 30 years of success and leadership from his broad experience at Stryker, one of the world’s leading medical technology companies. During his time as President and C.O.O., Mr. Scannell was responsible for all commercial businesses and regions globally for Stryker and delivered market-leading results.  During his early career, Mr. Scannell led Stryker’s neurotechnology, spine, and medsurg businesses.  Additionally, he served as general manager of Stryker’s biotech division.  Mr. Scannell currently serves as Chair of Insulet Corporation’s board of directors. He also serves on the board of directors for Novocure.

“Tim’s appointment represents a meaningful addition to our board, and I look forward to the strength and experience he will bring to the table” said Shawn McCarthy, President and Chief Executive Officer of Collagen Matrix, Inc. “He joins Collagen Matrix at an exciting time as we continue to accelerate our growth strategy and further our vision of improving patient lives through innovative regenerative devices. We are confident that Tim’s diversified leadership experience and proven track record will provide valuable perspective.”

Mr. Scannell holds a Bachelor of Business Administration and a Master of Business Administration from the University of Notre Dame.

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr. Val Kolesnitchenko brings extensive ophthalmology experience in clinical practice and industry to new therapeutics for the aging eye.
These strategic appointments signify a significant milestone for BRIJ Medical as they usher in a new era of post-surgical and trauma incision care with proven technologies that minimize wound complications and scarring.
Dr. Eckhard von Keutz has extensive experience in designing and conducting preclinical/toxicological studies, and toxicological risk assessment and management.
David Kroekel has more than 35 years of experience in medical device, combination product operations, and product development.
Dr. Konstantin Kousoulas, a leading virologist will work to further Rational Vaccines core mission of eradicating the world of the herpes simplex virus. "Dr. Kousoulas...

By using this website you agree to accept Medical Device News Magazine Privacy Policy